{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:40:27Z","timestamp":1784774427744,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,4,13]],"date-time":"2006-04-13T00:00:00Z","timestamp":1144886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,4,13]],"date-time":"2006-04-13T00:00:00Z","timestamp":1144886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1038\/sj.jhh.1002024","type":"journal-article","created":{"date-parts":[[2006,4,15]],"date-time":"2006-04-15T06:03:35Z","timestamp":1145081015000},"page":"482-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension"],"prefix":"10.1038","volume":"20","author":[{"given":"S A R","family":"Doi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Abalkhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Al-Qudhaiby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Al-Humood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M F","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K A S","family":"Al-Shoumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,4,13]]},"reference":[{"key":"BF1002024_CR1","first-page":"645","volume":"21","author":"BR Hemmelgarn","year":"2005","unstructured":"Hemmelgarn BR, McAllister FA, Myers MG, McKay DW, Bolli P, Abbott C et al. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 \u2013 blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2005; 21: 645\u2013656.","journal-title":"Can J Cardiol"},{"key":"BF1002024_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.tem.2005.02.007","volume":"16","author":"P Mulatero","year":"2005","unstructured":"Mulatero P, Dluhy RG, Giacchetti G, Boscaro M, Veglio F, Stewart PM . Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005; 16: 114\u2013119.","journal-title":"Trends Endocrinol Metab"},{"key":"BF1002024_CR3","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","volume":"339","author":"A Ganguly","year":"1998","unstructured":"Ganguly A . Primary aldosteronism. N Engl J Med 1998; 339: 1828\u20131834.","journal-title":"N Engl J Med"},{"key":"BF1002024_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","volume":"20","author":"RD Gordon","year":"1993","unstructured":"Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA . Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993; 20: 296\u2013298.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF1002024_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC . High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315\u2013318.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF1002024_CR6","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young Jr WF . Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85: 2854\u20132859.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1002024_CR7","first-page":"1863","volume":"85","author":"CE Fardella","year":"2000","unstructured":"Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863\u20131867.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1002024_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L et al. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension 2002; 40: 897\u2013902.","journal-title":"Hypertension"},{"key":"BF1002024_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(00)04223-9","volume":"357","author":"NM Kaplan","year":"2001","unstructured":"Kaplan NM . Cautions over the current epidemic of primary aldosteronism. Lancet 2001; 357: 953\u2013954.","journal-title":"Lancet"},{"key":"BF1002024_CR10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045\u20131050.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1002024_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","volume":"217","author":"M Stowasser","year":"2004","unstructured":"Stowasser M, Gordon RD . Primary aldosteronism \u2013 careful investigation is essential and rewarding. Mol Cell Endocrinol 2004; 217: 33\u201339.","journal-title":"Mol Cell Endocrinol"},{"key":"BF1002024_CR12","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0895-7061(98)00080-6","volume":"11","author":"JD Blumenfeld","year":"1998","unstructured":"Blumenfeld JD, Laragh JH . Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension. Am J Hypertens 1998; 11: 894\u2013896.","journal-title":"Am J Hypertens"},{"key":"BF1002024_CR13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1210\/jcem-73-5-952","volume":"73","author":"TJ McKenna","year":"1991","unstructured":"McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S . Diagnosis under random conditions of all disorders of the renin\u2013angiotensin\u2013aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991; 73: 952\u2013957.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1002024_CR14","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","volume":"141","author":"K Hiramatsu","year":"1981","unstructured":"Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 1981; 141: 1589\u20131593.","journal-title":"Arch Intern Med"},{"key":"BF1002024_CR15","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1001\/archinte.1993.00410180075008","volume":"153","author":"MH Weinberger","year":"1993","unstructured":"Weinberger MH, Fineberg NS . The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 1993; 153: 2125\u20132129.","journal-title":"Arch Intern Med"},{"key":"BF1002024_CR16","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1210\/en.2003-0279","volume":"144","author":"WF Young Jr","year":"2003","unstructured":"Young Jr WF . Minireview: primary aldosteronism \u2013 changing concepts in diagnosis and treatment. Endocrinology 2003; 144: 2208\u20132213.","journal-title":"Endocrinology"},{"key":"BF1002024_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/jc.2004-1149","volume":"90","author":"SC Tiu","year":"2005","unstructured":"Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005; 90: 72\u201378.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1002024_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","volume":"31","author":"VM Montori","year":"2002","unstructured":"Montori VM, Young Jr WF . Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 2002; 31: 619\u2013632, xi.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BF1002024_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2265.2003.01841.x","volume":"59","author":"PO Lim","year":"2003","unstructured":"Lim PO, MacDonald TM . Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension. Clin Endocrinol (Oxford) 2003; 59: 427\u2013430.","journal-title":"Clin Endocrinol (Oxford)"},{"key":"BF1002024_CR20","first-page":"37","volume":"61","author":"SJ Baas","year":"2003","unstructured":"Baas SJ, Endert E, Fliers E, Prummel MF, Wiersinga WM . Establishment of reference values for endocrine tests. III: Primary aldosteronism. Neth J Med 2003; 61: 37\u201343.","journal-title":"Neth J Med"},{"key":"BF1002024_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1440-1681.1985.tb02641.x","volume":"12","author":"SM Hamlet","year":"1985","unstructured":"Hamlet SM, Tunny TJ, Woodland E, Gordon RD . Is aldosterone\/renin ratio useful to screen a hypertensive population for primary aldosteronism? Clin Exp Pharmacol Physiol 1985; 12: 249\u2013252.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF1002024_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","volume":"51","author":"GL Schwartz","year":"2005","unstructured":"Schwartz GL, Turner ST . Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005; 51: 386\u2013394.","journal-title":"Clin Chem"},{"key":"BF1002024_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.amjhyper.2005.01.002","volume":"18","author":"MK Nishizaka","year":"2005","unstructured":"Nishizaka MK, Pratt-Ubunama M, Zaman MA, Cofield S, Calhoun DA . Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am J Hypertens 2005; 18: 805\u2013812.","journal-title":"Am J Hypertens"},{"key":"BF1002024_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(94)93003-1","volume":"344","author":"RD Gordon","year":"1994","unstructured":"Gordon RD . Mineralocorticoid hypertension. Lancet 1994; 344: 240\u2013243.","journal-title":"Lancet"},{"key":"BF1002024_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1590\/S0004-27302004000500013","volume":"48","author":"CE Kater","year":"2004","unstructured":"Kater CE, Biglieri EG . The syndromes of low-renin hypertension: \u2018separating the wheat from the chaff\u2019. Arq Bras Endocrinol Metabol 2004; 48: 674\u2013681.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"BF1002024_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.tem.2005.02.006","volume":"16","author":"JE Sealey","year":"2005","unstructured":"Sealey JE, Gordon RD, Mantero F . Plasma renin and aldosterone measurements in low renin hypertensive states. Trends Endocrinol Metab 2005; 16: 86\u201391.","journal-title":"Trends Endocrinol Metab"},{"key":"BF1002024_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00045415-199907000-00012","volume":"7","author":"WF Young Jr","year":"1999","unstructured":"Young Jr WF . Primary aldosteronism: a common and curable form of hypertension. Cardiol Rev 1999; 7: 207\u2013214.","journal-title":"Cardiol Rev"},{"key":"BF1002024_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","volume":"15","author":"E Rossi","year":"2002","unstructured":"Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F . High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 2002; 15: 896\u2013902.","journal-title":"Am J Hypertens"},{"key":"BF1002024_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2265.1992.tb02252.x","volume":"36","author":"C Hambling","year":"1992","unstructured":"Hambling C, Jung RT, Gunn A, Browning MC, Bartlett WA . Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. Clin Endocrinol (Oxford) 1992; 36: 499\u2013503.","journal-title":"Clin Endocrinol (Oxford)"},{"key":"BF1002024_CR30","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1210\/jcem-57-5-892","volume":"57","author":"DF Lyons","year":"1983","unstructured":"Lyons DF, Kem DC, Brown RD, Hanson CS, Carollo ML . Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 1983; 57: 892\u2013896.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1002024_CR31","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","volume":"37","author":"M Agharazii","year":"2001","unstructured":"Agharazii M, Douville P, Grose JH, Lebel M . Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 2001; 37: 1440\u20131443.","journal-title":"Hypertension"},{"key":"BF1002024_CR32","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/01.HYP.0000014324.68506.CA","volume":"39","author":"OL Castro","year":"2002","unstructured":"Castro OL, Yu X, Kem DC . Diagnostic value of the post-captopril test in primary aldosteronism. Hypertension 2002; 39: 935\u2013938.","journal-title":"Hypertension"},{"key":"BF1002024_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2002-23491","volume":"110","author":"S Trenkel","year":"2002","unstructured":"Trenkel S, Seifarth C, Schobel H, Hahn EG, Hensen J . Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Exp Clin Endocrinol Diabetes 2002; 110: 80\u201385.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"BF1002024_CR34","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1373\/clinchem.2004.033159","volume":"50","author":"FH Perschel","year":"2004","unstructured":"Perschel FH, Schemer R, Seiler L, Reincke M, Deinum J, Maser-Gluth C et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem 2004; 50: 1650\u20131655.","journal-title":"Clin Chem"},{"key":"BF1002024_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00004872-200402000-00023","volume":"22","author":"P Ferrari","year":"2004","unstructured":"Ferrari P, Shaw SG, Nicod J, Saner E, Nussberger J . Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. J Hypertens 2004; 22: 377\u2013381.","journal-title":"J Hypertens"},{"key":"BF1002024_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11906-002-0014-5","volume":"4","author":"MC Racine","year":"2002","unstructured":"Racine MC, Douville P, Lebel M . Functional tests for primary aldosteronism: value of captopril suppression. Curr Hypertens Rep 2002; 4: 245\u2013249.","journal-title":"Curr Hypertens Rep"},{"key":"BF1002024_CR37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF03349761","volume":"18","author":"RD Gordon","year":"1995","unstructured":"Gordon RD . Primary aldosteronism. J Endocrinol Invest 1995; 18: 495\u2013511.","journal-title":"J Endocrinol Invest"},{"key":"BF1002024_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2265.1995.tb01850.x","volume":"42","author":"MB Vallotton","year":"1995","unstructured":"Vallotton MB, Rossier MF, Capponi AM . Potassium-angiotensin interplay in the regulation of aldosterone biosynthesis. Clin Endocrinol (Oxford) 1995; 42: 111\u2013119.","journal-title":"Clin Endocrinol (Oxford)"},{"key":"BF1002024_CR39","first-page":"323","volume":"75","author":"K Nomura","year":"1992","unstructured":"Nomura K, Toraya S, Horiba N, Ujihara M, Aiba M, Demura H . Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone producing adenoma. J Clin Endocrinol Metab 1992; 75: 323\u2013327.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1002024_CR40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","volume":"57","author":"C Seifarth","year":"2002","unstructured":"Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J . Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol (Oxford) 2002; 57: 457\u2013465.","journal-title":"Clin Endocrinol (Oxford)"},{"key":"BF1002024_CR41","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1210\/jc.2002-021476","volume":"88","author":"A Tanabe","year":"2003","unstructured":"Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K . Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab 2003; 88: 2489\u20132494.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1002024_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0889-8529(18)30097-5","volume":"23","author":"EL Bravo","year":"1994","unstructured":"Bravo EL . Primary aldosteronism. Issues in diagnosis and management. Endocrinol Metab Clin North Am 1994; 23: 271\u2013283.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BF1002024_CR43","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11886-005-0058-7","volume":"7","author":"MK Nishizaka","year":"2005","unstructured":"Nishizaka MK, Calhoun DA . Primary aldosteronism: diagnostic and therapeutic considerations. Curr Cardiol Rep 2005; 7: 412\u2013417.","journal-title":"Curr Cardiol Rep"},{"key":"BF1002024_CR44","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1210\/jcem.86.9.7867","volume":"86","author":"D Hirohara","year":"2001","unstructured":"Hirohara D, Nomura K, Okamoto T, Ujihara M, Takano K . Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab 2001; 86: 4292\u20134298.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1002024_CR45","first-page":"1459","volume":"6","author":"K Ogawa","year":"1984","unstructured":"Ogawa K, Matsunaga M, Pak CH, Hara A, Kawai C . Synchronous changes in active and inactive renin secretion after furosemide in patients with primary aldosteronism. Clin Exp Hypertens A 1984; 6: 1459\u20131467.","journal-title":"Clin Exp Hypertens A"},{"key":"BF1002024_CR46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1253\/jcj.44.719","volume":"44","author":"M Honda","year":"1980","unstructured":"Honda M, Izumi Y, Tsuchiya M, Ueda Y, Watanabe H, Inoue T et al. A simplified screening test for differentiating primary aldosteronism from essential hypertension with low plasma renin activity. Jpn Circ J 1980; 44: 719\u2013725.","journal-title":"Jpn Circ J"},{"key":"BF1002024_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2265.1996.tb02059.x","volume":"45","author":"MB Vallotton","year":"1996","unstructured":"Vallotton MB . Primary aldosteronism. Part I. Diagnosis of primary hyperaldosteronism. Clin Endocrinol (Oxford) 1996; 45: 47\u201352.","journal-title":"Clin Endocrinol (Oxford)"},{"key":"BF1002024_CR48","doi-asserted-by":"publisher","first-page":"386","DOI":"10.7326\/0003-4819-90-3-386","volume":"90","author":"MH Weinberger","year":"1979","unstructured":"Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ et al. Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med 1979; 90: 386\u2013395.","journal-title":"Ann Intern Med"},{"key":"BF1002024_CR49","first-page":"181","volume":"98","author":"P Gosse","year":"2005","unstructured":"Gosse P, Guiheneuf-Tobie C, Lasserre R, Minifie C, Lemetayer P, Clementy J . Biochemical detection of Conn's adenoma: definition of criteria and reference values. Arch Mal Coeur Vaiss 2005; 98: 181\u2013185.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"BF1002024_CR50","first-page":"17","volume":"58","author":"A Prejbisz","year":"2003","unstructured":"Prejbisz A, Postula M, Cybulska I, Dobrucki T, Kabat M, Peczkowska M et al. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism. Kardiol Pol 2003; 58: 17\u201326.","journal-title":"Kardiol Pol"},{"key":"BF1002024_CR51","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1530\/eje.0.1500517","volume":"150","author":"N Unger","year":"2004","unstructured":"Unger N, Lopez Schmidt I, Pitt C, Walz MK, Philipp T, Mann K et al. Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. Eur J Endocrinol 2004; 150: 517\u2013523.","journal-title":"Eur J Endocrinol"},{"key":"BF1002024_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1530\/eje.0.1500329","volume":"150","author":"L Seiler","year":"2004","unstructured":"Seiler L, Rump LC, Schulte-Monting J, Slawik M, Borm K, Pavenstadt H et al. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol 2004; 150: 329\u2013337.","journal-title":"Eur J Endocrinol"},{"key":"BF1002024_CR53","first-page":"166","volume":"13","author":"BL Rayner","year":"2002","unstructured":"Rayner BL . Screening and diagnosis of primary aldosteronism. Cardiovasc J S Afr 2002; 13: 166\u2013170.","journal-title":"Cardiovasc J S Afr"},{"key":"BF1002024_CR54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3317\/jraas.2001.022","volume":"2","author":"M Stowasser","year":"2001","unstructured":"Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ . Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2001; 2: 156\u2013169.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"BF1002024_CR55","first-page":"264","volume":"28","author":"DC Kem","year":"1971","unstructured":"Kem DC, Mayes D, Weinberger M, Nugent CA . Saline suppression of plasma aldosterone and plasma renin activity in hypertension. Ariz Med 1971; 28: 264\u2013266.","journal-title":"Ariz Med"},{"key":"BF1002024_CR56","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0002-9343(79)90786-1","volume":"67","author":"DH Streeten","year":"1979","unstructured":"Streeten DH, Tomycz N, Anderson GH . Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 1979; 67: 403\u2013413.","journal-title":"Am J Med"},{"key":"BF1002024_CR57","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","volume":"37","author":"BJ Gallay","year":"2001","unstructured":"Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC . Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone\u2013renin ratio. Am J Kidney Dis 2001; 37: 699\u2013705.","journal-title":"Am J Kidney Dis"},{"key":"BF1002024_CR58","first-page":"1263","volume":"11","author":"G Carpene","year":"1989","unstructured":"Carpene G, Rocco S, Opocher G, Mantero F . Acute and chronic effect of nifedipine in primary aldosteronism. Clin Exp Hypertens A 1989; 11: 1263\u20131272.","journal-title":"Clin Exp Hypertens A"},{"key":"BF1002024_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/pgmj.75.882.235","volume":"75","author":"MJ Brown","year":"1999","unstructured":"Brown MJ, Hopper RV . Calcium-channel blockade can mask the diagnosis of Conn's syndrome. Postgrad Med J 1999; 75: 235\u2013236.","journal-title":"Postgrad Med J"},{"key":"BF1002024_CR60","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","volume":"14","author":"PO Lim","year":"2000","unstructured":"Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM . High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000; 14: 311\u2013315.","journal-title":"J Hum Hypertens"},{"key":"BF1002024_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7861\/clinmedicine.5-1-55","volume":"5","author":"S Hood","year":"2005","unstructured":"Hood S, Cannon J, Foo R, Brown M . Prevalence of primary hyperaldosteronism assessed by aldosterone\/renin ratio and spironolactone testing. Clin Med 2005; 5: 55\u201360.","journal-title":"Clin Med"},{"key":"BF1002024_CR62","first-page":"265","volume":"1","author":"GT Griffing","year":"1985","unstructured":"Griffing GT, Melby JC . The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic hyperaldosteronism. J Clin Hypertens 1985; 1: 265\u2013276.","journal-title":"J Clin Hypertens"},{"key":"BF1002024_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjhyper.2004.08.025","volume":"18","author":"M Lamarre-Cliche","year":"2005","unstructured":"Lamarre-Cliche M, de Champlain J, Lacourciere Y, Poirier L, Karas M, Larochelle P . Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives. Am J Hypertens 2005; 18: 56\u201364.","journal-title":"Am J Hypertens"},{"key":"BF1002024_CR64","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/07435809209035402","volume":"18","author":"MS Gordon","year":"1992","unstructured":"Gordon MS, Williams GH, Hollenberg NK . Renal and adrenal responsiveness to angiotensin II: influence of beta adrenergic blockade. Endocr Res 1992; 18: 115\u2013131.","journal-title":"Endocr Res"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1002024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1002024","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1002024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T15:37:51Z","timestamp":1647531471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1002024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,13]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7,1]]}},"alternative-id":["BF1002024"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1002024","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,13]]},"assertion":[{"value":"11 October 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}